A Double Blind Randomized Placebo Controlled Clinical Trial for the Add-On Treatment of Schizophrenia Using a Selected Nmda Receptor Modulator

Project title

使用選擇性NMDA受體調節劑附加治療思覺失調症的雙盲隨機安慰劑對照臨床試驗

Internal ID

MOST107-2314-B002-221

Principal Investigator

Start Date

August 1, 2018

End Date

July 31, 2019

Organizations

Partner Organizations

National Science and Technology Council